Investigating how certain enzymes affect recovery from brain injuries and dementia.
Pharmacological inhibition of NEP-like enzymes in traumatic brain injury and dementia
This study is looking at how certain enzymes might help the brain heal after a traumatic brain injury and how they could be connected to dementia, with the hope that what we learn could lead to better treatments for both conditions.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Rosalind Franklin Univ of Medicine & Sci NIH-funded |
| Lab location | 1 site (North Chicago, United States) |
| Project ID | NIH-11088216 on NIH RePORTER |
What this research studies
This research explores the role of NEP-like enzymes in the recovery process following traumatic brain injury (TBI) and their potential link to the development of dementia. By using humanized transgenic mice, the study will manipulate the activity of these enzymes to assess their impact on amyloid-beta peptide levels, which are crucial for brain health. The research aims to understand both the immediate and long-term effects of these enzymes on brain recovery and dementia risk. Patients may benefit from insights that could lead to new treatments for TBI and dementia.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals who have experienced a traumatic brain injury or are at risk for dementia.
Not a fit: Patients with conditions unrelated to traumatic brain injury or dementia may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic strategies for improving recovery from traumatic brain injuries and reducing the risk of developing dementia.
How similar studies have performed: Other research has shown promising results in understanding the role of amyloid-beta clearance in brain injuries, suggesting that this approach may yield valuable insights.
Where this research is happening
North Chicago, United States
- Rosalind Franklin Univ of Medicine & Sci — North Chicago, United States (Active)
Researchers
- Principal investigator: Marr, Robert Anthony — Rosalind Franklin Univ of Medicine & Sci
- Study coordinator: Marr, Robert Anthony
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.